This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galindo, C. L.
Right arrow Articles by Chopra, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galindo, C. L.
Right arrow Articles by Chopra, A. K.

 Previous Article  |  Next Article 

Infection and Immunity, September 2004, p. 5439-5445, Vol. 72, No. 9
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.9.5439-5445.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Microarray Analysis of Aeromonas hydrophila Cytotoxic Enterotoxin-Treated Murine Primary Macrophages

C. L. Galindo, A. A. Fadl, J. Sha, and A. K. Chopra*

Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas 77555-1070

Received 17 March 2004/ Returned for modification 4 May 2004/ Accepted 14 May 2004


arrow
ABSTRACT
 
We performed microarray analyses of murine peritoneal macrophages to examine cellular transcriptional responses to a cytotoxic enterotoxin of Aeromonas hydrophila. While 66% of altered genes were common to both primary macrophages and the murine macrophage cell line RAW 264.7, Act caused expression changes of 28 genes specifically in murine peritoneal macrophages.


arrow
TEXT
 
Aeromonas species are significant human pathogens that cause both gastrointestinal and nonintestinal diseases in children and adults (11, 22). Our laboratory isolated and molecularly characterized a cytotoxic enterotoxin (Act) from A. hydrophila that caused lysis of red blood cells, was cytotoxic to intestinal and nonintestinal cells, evoked intestinal fluid secretion, and was lethal when injected intravenously into mice (11, 15, 38). Recently, we performed microarray analyses of Act-treated RAW 264.7 murine macrophages in order to obtain a global view of transcriptional responses and to identify genes previously not known to be involved in Act-induced host cell signaling (18). This study directly led to the discovery that Act induced apoptosis in murine macrophages (18). Because signaling pathways in the transformed cell line could differ from those that occur in primary macrophages recruited during infection (3, 20, 33, 34), we performed microarray analysis of Act-treated murine primary (peritoneal) macrophages and compared that to previous data obtained with RAW 264.7 cells (18) in order to identify common and unique Act-induced genes in these cells.

Transcriptional alteration of genes in murine primary macrophages. Thioglycolate-induced peritoneal macrophages (9) were treated with a sublethal dose of Act (6 ng/ml) for 0 and 2 h (in triplicate), and the RNA was isolated and applied to MGU74Av2 GeneChips (18). In one experiment, the macrophages were treated with Act for 45 min, and the RNA was applied to a single array. The data were analyzed separately by using four different techniques: MAS 5.0, significance of analysis of microarrays (SAM; software program from Stanford), Spotfire 7.1, and analysis of variance (ANOVA) (18). Because only one experiment was performed for Act treatment at 45 min, a change in gene expression from 0 to 45 min was considered significant only if it also occurred between 0 and 2 h. Genes that were deemed significant by all four analysis techniques were compiled into a list that included 90 probe sets representing 81 genes for 0- versus 2-h treatments (data not shown). The majority of the significant genes were associated with inflammation, immune responses, or apoptosis, as we previously demonstrated in microarray findings from Act-treated RAW 264.7 cells (18). However, out of the 81 altered genes, there were 22 genes that were up-regulated by Act in only primary macrophages, such as the interferon regulatory factor 1 (IRF-1) gene, myeloid differentiation primary response gene 116 (MyD116), the chemokine receptor-like 2 (L-CCR) gene, the neutrophil chemoattractant growth-related oncogene 1 (GRO1), the apoptosis-associated tumor necrosis factor (TNF) receptor superfamily member 5 (TRAP) gene, a cDNA representing Ras-related protein Rab-20, and the GTP binding protein (GEM) gene (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Most significant genes up-regulated or down-regulated by Act in murine peritoneal macrophages from 0 to 2 h as determined by four separate analysis methods

IRF-1 is an interleukin-6 (IL-6)-induced transcriptional activator of the beta interferon (IFN-ß) gene that plays a central role in host immune and inflammatory responses (42). IRF-1 has also been implicated in p53-independent, DNA damage-induced apoptosis of activated T cells and in macrophage-mediated tumor cell apoptotic death (41, 43). Like IRF-1, MyD116 is rapidly induced by IL-6 and expressed in bone marrow cells (27, 29). MyD116 has been reported to be induced by growth arrest and DNA damage stimuli, such as alkylating agents and irradiation, and by diverse apoptotic stimuli (2, 16, 17, 21).

L-CCR, a C-C chemokine receptor originally isolated as a lipopolysaccharide (LPS)-inducible gene in RAW 264.7 cells (39), was also up-regulated by Act only in murine peritoneal macrophages (Table 1). L-CCR is thought to be activated by monocyte chemotactic protein-1 (MCP-1) (45), which has been suggested to play a role in control of bacterial infections and neuroinflammatory processes. While the function of L-CCR has yet to be elucidated, a study of the receptor in HEK 293 cells, a human kidney cell line, demonstrated pertussis toxin-sensitive chemotaxis and small, transient calcium fluxes in response to MCP-1, MCP-2, MCP-3, and RANTES (regulated on activation, normal T-cell expressed) (7). L-CCR has also been implicated in the recruitment and activation of macrophages in the lung, possibly in the early phase of airway inflammation in response to allergens (32). It is therefore likely that L-CCR is a functional chemokine receptor, which may play a role in leukocyte recruitment during Aeromonas-associated infections and likely contributes to the acute inflammatory response of the host.

GRO1 (also called KC), is an inflammatory chemokine involved in neutrophil recruitment (8, 36). TRAP (also called CD40) is a TNF receptor superfamily member which mediates the activation of multiple signaling pathways, including NF-{kappa}B, c-Jun NH2-terminal kinase (JNK), and p38 kinase (5, 6, 26, 44). Rab-20 is a GTP binding protein involved in the membrane trafficking mechanism (30), and GEM binds Ca2+ and calmodulin and has been proposed to regulate Ca2+ channel expression at the cell surface (4). While the involvement of L-CCR, GRO1, MyD116, IRF-1, and TRAP in immune-related responses seems clear, how Rab-20 and GEM might contribute to inflammation or other host response signaling involved in the mechanism of action of Act requires further study.

There were also six genes that were down-regulated in Act-treated murine primary macrophages (Table 1) but not in RAW 264.7 cells (18), such as the MafB and suppressor of cytokine signaling (SOCS) box protein (SSB-1) genes. MafB is an essential transcription factor involved in the differentiation of multipotent myeloid progenitors to macrophages (23), and Act-induced down-regulation of this gene could conceivably interfere with the ability of host macrophages to respond effectively during Aeromonas-associated infection. While the function of SSB-1 is not known, it does contain a SOCS box domain typical of proteins that suppress the production of cytokines (1, 24). It is possible that Act-induced down-regulation of SSB-1 leads to an inability of host macrophages to dampen cytokine production, which would lead to increased inflammation. Act-induced alteration in the expression of the SSB-1 gene and other genes with unknown function (Table 1) are prospects for future research aimed at characterizing the mechanism of action of Act.

The biological consequences of differences between Act-induced responses of RAW 264.7 cells and murine peritoneal macrophages also require further investigation, as subtle differences may not affect the overall outcome where redundancy occurs. For instance, macrophage inflammatory proteins (Mip-1{alpha}, Mip-1ß, and Mip-2), which were up-regulated by Act in both RAW 264.7 cells (18) and peritoneal macrophages (data not shown), function similarly to GRO1, in that they are known to recruit neutrophils and have been associated with inflammatory diseases (14, 31, 37, 40). Also, MyD116 functions similarly to growth arrest and DNA damage-inducible 45{alpha} (GADD45{alpha}) and MyD118/GADD45ß (27), the latter two of which were induced upon Act treatment in both RAW 264.7 cells (18) and murine peritoneal macrophages (data not shown).

Confirmation of up-regulated genes in murine peritoneal macrophages by real-time RT-PCR. In order to confirm the microarray data, real-time reverse transcriptase-PCR (RT-PCR) was performed on selected genes (Table 2). Experiments were run in parallel, and fold change values were determined after normalization of each gene to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene by using the comparative threshold method (28). We chose 7 genes (out of 22) for verification (Tables 1 and 2), based on their known involvement in stress and/or apoptosis and intracellular signaling related to immune responses. As shown in Table 2, L-CCR and GRO1 were up-regulated 4- to 4.5-fold and 18.9- to 24.7-fold, respectively, according to microarray analyses, and we verified up-regulation of L-CCR (59.3-fold) and GRO1 (49.2-fold) by real-time RT-PCR. Likewise, real-time RT-PCR verified Act-induced up-regulation of the other five genes. (Table 2).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Confirmation by real-time RT-PCR of selected genes determined to be up-regulated by Act in murine peritoneal macrophages by using microarrays

Because previous studies of Act-treated RAW 264.7 macrophages and the present study using microarrays indicated that Act's mode of action involved primarily up-regulation of host signaling molecules, rather than suppression, we did not choose to verify down-regulated genes by RT-PCR. Additionally, it is unclear how these down-regulated genes might contribute to the alteration of host cell signaling mediated by Act in the context of Aeromonas-associated diseases. Nonetheless, our laboratory plans to investigate these genes further in future.

Up-regulation of early inflammatory molecules in Act-treated murine peritoneal macrophages. We investigated Act-mediated gene expression changes in primary macrophages at 45 min to identify earlier transcriptional responses to Act, which yielded 15 genes. Six of these genes (Table 3) were for cytokines (TNF-{alpha}, Mip-2, IL-1{alpha}, IL-1ß, IL-6, and GRO-1). Immune response molecules were also up-regulated by 45 min, including SOCS3, a molecule possessing ankyrin repeats induced by LPS (MAIL), a member of the nuclear I{kappa}B family that has been shown to induce the production of IL-6 in response to LPS (25), and TNF receptor (ligand) superfamily member 9 (also called 4-IBB ligand or CD137 ligand), which upon binding to its receptor, CD137, stimulates both primary and secondary responses of CD4+ and CD8+ T cells (10).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Most significant genes up-regulated or down-regulated by Act in murine peritoneal macrophages from 0 to 45 min, with comparison to genes up- regulated from 0 to 2 h and with Act-treated RAW 264.7 cells

While microarray analyses of RAW 264.7 cells at 2 h did not reveal up-regulation of IL-6 (Table 3), our laboratory has previously demonstrated Act-induced production of IL-6 at the protein level (12). We therefore considered only two of the genes that were up-regulated by 45 min as unique to primary macrophages (the GRO1 and L-CCR genes) (Table 3). Future studies will be aimed at identifying which transcription factors or other signaling molecules are directly responsible for induction of these early genes in murine macrophages.

Act-induced genes follow a similar pattern of expression in primary macrophages. To identify groups of genes with similar expression patterns, we employed three separate software programs to perform hierarchical clustering: Cluster/Treeview, CLUSFAVOR 6.0, and Spotfire DecisionSite 7.1. Example clusters are shown in Fig. 1A (CLUSFAVOR) and B (Spotfire). There were 21 genes specifically altered in primary macrophages that consistently clustered together and that were also considered significant by four analysis techniques: MAS 5.0, SAM, Spotfire DecisionSite, and ANOVA (Fig. 1C). The similar expression patterns of these genes, as determined by clustering, suggested their involvement in the same signaling pathway or in separate but coregulated pathways.



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 1. Hierarchical clusters of genes from Act-treated murine peritoneal macrophages. Hierarchical cluster analysis was performed on signal values from seven arrays (0- and 2-h replicate experiments and a single experiment for 45 min), using CLUSFAVOR 6.0 and Spotfire DecisionSite 7.1. The Cluster/Treeview software programs were used to cluster fold change values generated from four experimental comparisons with murine peritoneal macrophages (three replicates of 0 versus 2 h and a single experiment for 0 versus 45 min). (A) Graphical representation of a cluster generated by using CLUSFAVOR 6.0 that represents a set of genes up-regulated by 2 h in Act-treated murine peritoneal macrophages. Normalized intensity values are displayed on the ordinate, and the abscissa represents each experiment. G451, G455A, and G455B represent the three independent experimental array sets (0 h, 45 min, and 2 h) with murine peritoneal macrophages. Error bars indicate standard deviations. (B) Clustering generated by using Spotfire DecisionSite 7.1, showing a set of up-regulated genes (similar to that generated by CLUSFAVOR 6.0). Higher signal values are shown in red, and lower signal values are shown in green. Black represents median signal values. (C) List of genes up-regulated by 2 h specifically in Act-treated murine peritoneal macrophages that clustered together for all three clustering programs used (Cluster/Treeview, CLUSFAVOR 6.0, and Spotfire DecisionSite 7.1).

To reduce the dimensions of the data, we also performed principal component analysis, which could group similarly expressed genes into functional sets (13, 18). Based on principal component analysis, nearly half of the Act-induced gene expression changes in murine peritoneal macrophages occurred by 45 min (data not shown). The majority of these genes were for cytokines and other immune response molecules.

Cytokine profile of Act-treated murine peritoneal macrophages. There were four cytokines, i.e., Mip-{alpha}, Mip-1ß, Mip-2, and TNF-{alpha}, that were induced by Act in both peritoneal macrophages (data not shown) and RAW 264.7 cells (18) according to microarray analyses, which we confirmed in both cell types by real-time RT-PCR or enzyme-linked immunosorbent assay. Additionally, Act induced up-regulation of IL-1ß and IL-6 in murine peritoneal macrophages. Although IL-1ß and IL-6 were not determined to be significantly up-regulated in RAW cells by stringent microarray analysis methods (18), we have shown by traditional laboratory techniques that Act induced these genes in RAW 264.7 cells (12, 18, 35). There were several cytokines that were significantly up-regulated in murine peritoneal macrophages but were not included in our original microarray study of Act-treated RAW cells, because they were not consistently altered by all of the statistical methods used. These cytokines included IFN-ß, IL-1{alpha}, macrophage interferon inducible protein 10 (IP-10), MCP-1, and RANTES. GRO1, on the other hand was considered specific for murine peritoneal macrophages (Tables 1 and 2).

To determine which cytokines were indeed produced in response to Act, we performed a broad cytokine profile analysis on supernatants of Act-treated murine peritoneal macrophages. We chose later time points than those used for microarray analyses (4 and 8 h) in order to examine levels of secreted proteins. There was no significant production of IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12 (p40), IL-17, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or IFN-{gamma} in response to Act. However, Act induced production of IL-1{alpha}, IL-1ß, and RANTES by 4 h and of TNF-{alpha} by 8 h, based on a multiplex cytokine assay (Fig. 2A), which supported the microarray analysis results. Act also up-regulated the bioactive heterodimer of IL-12 (p70), demonstrating for the first time the production and secretion of IL-12 by macrophages in response to Act (Fig. 2A). IL-12 (p40), which acts as an antagonist of IL-12 signaling (19), was not detected (data not shown).



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 2. Cytokine profiling for Act-treated murine peritoneal macrophages. Multiplex cytokine assays (Bio-plex; Bio-Rad, Richmond, Calif.) were performed on the supernatants of Act-treated murine peritoneal cells (0, 4, and 8 h). The concentrations of various cytokines are shown on the ordinate, cytokine names and time points are displayed on the abscissa, and a table below each graph displays the actual, normalized concentration of each cytokine. Results from a representative experiment from a total of three are shown.

A substantial increase in the production and secretion of Mip-1{alpha} was observed in response to Act (Fig. 2B), which was expected since Act-induced up-regulation of the transcript for Mip-1{alpha} was demonstrated by real-time RT-PCR (data not shown). Act also induced production and secretion of GRO1 (Fig. 2C), which was discovered in this study of primary macrophages by using microarrays and confirmed by real-time RT-PCR (Tables 1 and 2) but which was not demonstrated for RAW 264.7 cells (18).

This study showed, for the first time, Act-induced host transcriptional changes in murine primary macrophages. Act-induced genes in primary macrophages that were discovered by using microarrays, such as those for GRO1, L-CCR, and IRF-1, are prospects for future research and may aid in the further elucidation of the mechanism of action of Act.


arrow
ACKNOWLEDGMENTS
 
This work was supported by grants from the NIH/NIAID (AI41611) and the Gastrointestinal Research Interdisciplinary Program (GRIP), University of Texas Medical Branch (UTMB), Galveston. Cristi L. Galindo, a predoctoral fellow, obtained funding from the National Science Foundation.

T. Wood, from the Department of Human Biological Chemistry and Genetics at UTMB, provided facility of his core laboratory for microarray studies. V. Reyes, from the Department of Pediatrics at UTMB, provided facility of his core laboratory for cytokine profile assays. Microsoft professional Celso Gutierrez, Jr., provided computer software and graphics expertise.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Medical Research Building, 301 University Boulevard, University of Texas Medical Branch, Galveston, TX 77555-1070. Phone: (409) 747-0578. Fax: (409) 747-6869. E-mail: achopra{at}utmb.edu. Back

Editor: J. T. Barbieri


arrow
REFERENCES
 
    1
  1. Alexander, W. S., R. Starr, D. Metcalf, S. E. Nicholson, A. Farley, A. G. Elefanty, M. Brysha, B. T. Kile, R. Richardson, M. Baca, J. G. Zhang, T. A. Willson, E. M. Viney, N. S. Sprigg, S. Rakar, J. Corbin, S. Mifsud, L. DiRago, D. Cary, N. A. Nicola, and D. J. Hilton. 1999. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J. Leukoc. Biol. 66:588-592.[Abstract]
  2. 2
  3. Amundson, S. A., T. G. Myers, D. Scudiero, S. Kitada, J. C. Reed, and A. J. Fornace, Jr. 2000. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60:6101-6110.[Abstract/Free Full Text]
  4. 3
  5. Barbour, S. E., C. Wong, D. Rabah, A. Kapur, and A. D. Carter. 1998. Mature macrophage cell lines exhibit variable responses to LPS. Mol. Immunol. 35:977-987.[CrossRef][Medline]
  6. 4
  7. Beguin, P., K. Nagashima, T. Gonoi, T. Shibasaki, K. Takahashi, Y. Kashima, N. Ozaki, K. Geering, T. Iwanaga, and S. Seino. 2001. Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem. Nature 411:701-706.[CrossRef][Medline]
  8. 5
  9. Berberich, I., G. Shu, and E. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 153:4357-4366.[Abstract]
  10. 6
  11. Berberich, I., G. Shu, F. Siebelt, J. Woodgett, J. Kyriakis, and E. Clark. 1996. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15:92-101.[Medline]
  12. 7
  13. Biber, K., M. W. Zuurman, H. Homan, and H. W. Boddeke. 2003. Expression of L-CCR in HEK 293 cells reveals functional responses to CCL2, CCL5, CCL7, and CCL8. J. Leukoc. Biol. 74:243-251.[Abstract/Free Full Text]
  14. 8
  15. Brown, C. R., V. A. Blaho, and C. M. Loiacono. 2003. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 171:893-901.[Abstract/Free Full Text]
  16. 9
  17. Brownstein, C., A. B. Deora, A. T. Jacovina, R. Weintraub, M. Gertler, K. M. F. Khan, D. J. Falcone, and K. A. Hajjar. 2004. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood 103:317-324.[Abstract/Free Full Text]
  18. 10
  19. Cannons, J. L., P. Lau, B. Ghumman, M. A. DeBenedette, H. Yagita, K. Okumura, and T. H. Watts. 2001. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:1313-1324.[Abstract/Free Full Text]
  20. 11
  21. Chopra, A. K., and C. W. Houston. 1999. Enterotoxins in Aeromonas-associated gastroenteritis. Microbes Infect. 1:1129-1137.[CrossRef][Medline]
  22. 12
  23. Chopra, A. K., X. Xu, D. Ribardo, M. Gonzalez, K. Kuhl, J. W. Peterson, and C. W. Houston. 2000. The cytotoxic enterotoxin of Aeromonas hydrophila induces proinflammatory cytokine production and activates arachidonic acid metabolism in macrophages. Infect. Immun. 68:2808-2818.[Abstract/Free Full Text]
  24. 13
  25. Crescenzi, M., and A. Giuliani. 2001. The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data. FEBS Lett. 507:114-118.[CrossRef][Medline]
  26. 14
  27. Feng, L., Y. Xia, T. Yoshimura, and C. B. Wilson. 1995. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Investig. 95:1009-1017.
  28. 15
  29. Ferguson, M. R., X. J. Xu, C. W. Houston, J. W. Peterson, D. H. Coppenhaver, V. L. Popov, and A. K. Chopra. 1997. Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila. Infect. Immun. 65:4299-4308.[Abstract]
  30. 16
  31. Fornace, A. J., Jr. 1992. Mammalian genes induced by radiation; activation of genes associated with growth control. Annu. Rev. Genet. 26:507-526.[Medline]
  32. 17
  33. Fornace, A. J., Jr., J. Jackman, M. C. Hollander, B. Hoffman-Liebermann, and D. A. Liebermann. 1992. Genotoxic-stress-response genes and growth-arrest genes. Gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann. N. Y. Acad. Sci. 663:139-153.[Medline]
  34. 18
  35. Galindo, C. L., J. Sha, D. A. Ribardo, A. A. Fadl, L. Pillai, and A. K. Chopra. 2003. Identification of Aeromonas hydrophila cytotoxic enterotoxin-induced genes in macrophages using microarrays. J. Biol. Chem. 278:40198-40212.[Abstract/Free Full Text]
  36. 19
  37. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, P. C. Familletti, et al. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88:4143-4147.[Abstract/Free Full Text]
  38. 20
  39. Hamilton, J. A., R. Byrne, G. Whitty, P. K. Vadiveloo, N. Marmy, R. B. Pearson, E. Christy, and A. Jaworowski. 1998. Effects of wortmannin and rapamycin on CSF-1-mediated responses in macrophages. Int. J. Biochem. Cell Biol. 30:271-283.[CrossRef][Medline]
  40. 21
  41. Hollander, M. C., M. S. Sheikh, K. Yu, Q. Zhan, M. Iglesias, C. Woodworth, and A. J. Fornace, Jr. 2001. Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors. Int. J. Cancer 96:22-31.[CrossRef][Medline]
  42. 22
  43. Janda, J. M., and S. L. Abbott. 1998. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin. Infect. Dis. 27:332-344.[Medline]
  44. 23
  45. Kelly, L. M., U. Englmeier, I. Lafon, M. H. Sieweke, and T. Graf. 2000. MafB is an inducer of monocytic differentiation. EMBO J. 19:1987-1997.[CrossRef][Medline]
  46. 24
  47. Kile, B. T., B. A. Schulman, W. S. Alexander, N. A. Nicola, H. M. E. Martin, and D. J. Hilton. 2002. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27:235-241.[CrossRef][Medline]
  48. 25
  49. Kitamura, H., K. Kanehira, K. Okita, M. Morimatsu, and M. Saito. 2000. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett. 485:53-56.[CrossRef][Medline]
  50. 26
  51. Li, Y., M. Baccam, S. Waters, J. Pessin, G. Bishop, and G. Koretzky. 1996. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J. Immunol. 157:1440-1447.[Abstract]
  52. 27
  53. Liebermann, D. A., and B. Hoffman. 2002. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene 21:3391-3402.[CrossRef][Medline]
  54. 28
  55. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.[CrossRef][Medline]
  56. 29
  57. Lord, K. A., B. Hoffman-Liebermann, and D. A. Liebermann. 1990. Sequence of MyD116 cDNA: a novel myeloid differentiation primary response gene induced by IL6. Nucleic Acids Res. 18:2823.[Free Full Text]
  58. 30
  59. Lutcke, A., R. G. Parton, C. Murphy, V. M. Olkkonen, P. Dupree, A. Valencia, K. Simons, and M. Zerial. 1994. Cloning and subcellular localization of novel rab proteins reveals polarized and cell type-specific expression. J. Cell Sci. 107:3437-3448.[Abstract]
  60. 31
  61. Ohtsuka, Y., J. Lee, D. S. Stamm, and I. R. Sanderson. 2001. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 49:526-533.[Abstract/Free Full Text]
  62. 32
  63. Oostendorp, J., M. N. Hylkema, M. Luinge, M. Geerlings, H. Meurs, W. Timens, J. Zaagsma, D. S. Postma, H. W. Boddeke, and K. Biber. 2004. Localization and enhanced mRNA expression of the orphan chemokine receptor L-CCR in the lung in a murine model of ovalbumin-induced airway inflammation. J. Histochem. Cytochem. 52:401-410.[Abstract/Free Full Text]
  64. 33
  65. Rao, K. M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3-10.[Abstract/Free Full Text]
  66. 34
  67. Rao, K. M., T. Meighan, and L. Bowman. 2002. Role of mitogen-activated protein kinase activation in the production of inflammatory mediators: differences between primary rat alveolar macrophages and macrophage cell lines. J. Toxicol. Environ. Health A 65:757-768.[CrossRef][Medline]
  68. 35
  69. Ribardo, D. A., K. R. Kuhl, I. Boldogh, J. W. Peterson, C. W. Houston, and A. K. Chopra. 2002. Early cell signaling by the cytotoxic enterotoxin of Aeromonas hydrophila in macrophages. Microb. Pathog. 32:149-163.[CrossRef][Medline]
  70. 36
  71. Schramm, R., T. Schaefer, M. D. Menger, and H. Thorlacius. 2002. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J. Leukoc. Biol. 72:1122-1132.[Abstract/Free Full Text]
  72. 37
  73. Schrier, D. J., R. C. Schimmer, C. M. Flory, D. K. Tung, and P. A. Ward. 1998. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J. Leukoc. Biol. 63:359-363.[Abstract]
  74. 38
  75. Sha, J., E. V. Kozlova, and A. K. Chopra. 2002. Role of various enterotoxins in Aeromonas hydrophila-induced gastroenteritis: generation of enterotoxin gene-deficient mutants and evaluation of their enterotoxic activity. Infect. Immun. 70:1924-1935.[Abstract/Free Full Text]
  76. 39
  77. Shimada, T., M. Matsumoto, Y. Tatsumi, A. Kanamaru, and S. Akira. 1998. A novel lipopolysaccharide inducible C-C chemokine receptor related gene in murine macrophages. FEBS Lett. 425:490-494.[CrossRef][Medline]
  78. 40
  79. Skidgel, R. A., X. P. Gao, V. Brovkovych, A. Rahman, D. Jho, S. Predescu, T. J. Standiford, and A. B. Malik. 2002. Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. J. Immunol. 169:2093-2101.[Abstract/Free Full Text]
  80. 41
  81. Tamura, T., M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki, and T. Taniguchi. 1995. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376:596-599.[CrossRef][Medline]
  82. 42
  83. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.[CrossRef][Medline]
  84. 43
  85. Tendler, D. S., C. Bao, T. Wang, E. L. Huang, E. A. Ratovitski, D. A. Pardoll, and C. J. Lowenstein. 2001. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res. 61:3682-3688.[Abstract/Free Full Text]
  86. 44
  87. Zhu, N., L. M. Ramirez, R. L. Lee, N. S. Magnuson, G. A. Bishop, and M. R. Gold. 2002. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-{kappa}B pathway. J. Immunol. 168:744-754.[Abstract/Free Full Text]
  88. 45
  89. Zuurman, M. W., J. Heeroma, N. Brouwer, H. W. Boddeke, and K. Biber. 2003. LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia 41:327-336.[CrossRef][Medline]


Infection and Immunity, September 2004, p. 5439-5445, Vol. 72, No. 9
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.9.5439-5445.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Galindo, C. L., Fadl, A. A., Sha, J., Pillai, L., Gutierrez, C. Jr., Chopra, A. K. (2005). Microarray and Proteomics Analyses of Human Intestinal Epithelial Cells Treated with the Aeromonas hydrophila Cytotoxic Enterotoxin. Infect. Immun. 73: 2628-2643 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galindo, C. L.
Right arrow Articles by Chopra, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galindo, C. L.
Right arrow Articles by Chopra, A. K.